This Week in Managed CarePharma Execs Testifies Before Congress and Other Health News

Published: March 2, 2019, 10 a.m.

Every week, The American Journal of Managed Care\xae\xa0(AJMC\xae) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care news included\xa0pharmaceutical executives appearing before a Senate drug pricing hearing; HHS finalizing a Title X rule change; and an analysis that found travel and wait times for healthcare services come with a high price.\n\nRead more about the stories in this podcast:\nSenate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions\nPharma Executives Call for Reforms to Medicare, Rebate System in Senate Hearing: https://www.ajmc.com/focus-of-the-week/pharma-executives-call-on-reforms-to-medicare-rebate-system-in-senate-hearing\nHHS Rule Bars Clinics That Perform Abortion, Make Referrals From Receiving Title X Funds: https://www.ajmc.com/newsroom/hhs-rule-bars-clinics-that-perform-abortion-make-referrals-from-receiving-title-x-funds\nHPV Vaccines Cut Cervical Cancer Rates, Study Shows: https://www.ajmc.com/newsroom/hpv-vaccination-safeguarding-against-cervical-cancer\nTravel, Wait Times for Healthcare Services Cost $89 Billion Annually: https://www.ajmc.com/focus-of-the-week/travel-wait-times-for-healthcare-services-cost-89-billion-annually\nAmerican Academy of Allergy, Asthma and Immunology 2019: https://www.ajmc.com/conferences/aaaai-2019